We develop therapies for rare genetic disorders. The first and only therapy for the treatment of hyperphagia in #PraderWilliSyndrome received full FDA-approval in March 2025.
C-US-VYK-00003
Shared 1 year ago
1.1K views
Shared 1 year ago
3.3K views
Shared 1 year ago
81 views
Shared 1 year ago
189 views
Shared 1 year ago
77 views
Shared 1 year ago
134 views
Shared 1 year ago
2.8K views
Shared 1 year ago
404 views
Shared 1 year ago
219 views
Shared 1 year ago
2.2K views
Shared 1 year ago
291 views
Shared 2 years ago
832 views
Shared 2 years ago
275 views